Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06733350	Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance	recruiting	Phase 4	600	Roswell Park Cancer InstituteOTHER	1	May 14, 2026	clinicaltrials
NCT06099093	Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan	recruiting	Phase 4	30	Brigham and Women's HospitalOTHER	1	Jan 29, 2026	clinicaltrials